Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Marso

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
JAMA|March 14, 2013
Association between bleeding events and in-hospital mortality after percutaneous coronary interventionAdnan K Chhatriwalla, Amit P Amin, Kevin F Kennedy, et al.
Diabetes & Vascular Disease Research|June 10, 2011
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studiesSteven P Marso, Jason B Lindsey, Joshua M Stolker, et al.
Circulation|February 13, 2008
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of riskMikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, et al.
The American Journal of Cardiology|October 5, 2015
Usefulness of Coronary Atheroma Burden to Predict Cardiovascular Events in Patients Presenting With Acute Coronary Syndromes (from the PROSPECT Study)Peiren Shan, Gary S Mintz, John A McPherson, et al.
European Heart Journal|October 27, 2009
Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registrySebastian Philipp, Dirk Böse, William Wijns, et al.
The New England Journal of Medicine|August 31, 2017
Liraglutide and Renal Outcomes in Type 2 DiabetesJohannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, et al.
JACC. Cardiovascular Imaging|July 4, 2016
Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT StudyElvin Kedhi, Mark W Kennedy, Akiko Maehara, et al.
The American Journal of Cardiology|June 14, 2003
Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart diseaseMehdi H Shishehbor, Byron J Hoogwerf, Paul Schoenhagen, et al.
JACC. Cardiovascular Imaging|October 21, 2015
Predictors of Plaque Rupture Within Nonculprit Fibroatheromas in Patients With Acute Coronary Syndromes: The PROSPECT StudyBo Zheng, Gary S Mintz, John A McPherson, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registryJoshua M Stolker, Kevin F Kennedy, Jason B Lindsey, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
JAMA|March 14, 2013
Association between bleeding events and in-hospital mortality after percutaneous coronary interventionAdnan K Chhatriwalla, Amit P Amin, Kevin F Kennedy, et al.
Diabetes & Vascular Disease Research|June 10, 2011
Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studiesSteven P Marso, Jason B Lindsey, Joshua M Stolker, et al.
Circulation|February 13, 2008
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of riskMikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, et al.
The American Journal of Cardiology|October 5, 2015
Usefulness of Coronary Atheroma Burden to Predict Cardiovascular Events in Patients Presenting With Acute Coronary Syndromes (from the PROSPECT Study)Peiren Shan, Gary S Mintz, John A McPherson, et al.
European Heart Journal|October 27, 2009
Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registrySebastian Philipp, Dirk Böse, William Wijns, et al.
The New England Journal of Medicine|August 31, 2017
Liraglutide and Renal Outcomes in Type 2 DiabetesJohannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, et al.
JACC. Cardiovascular Imaging|July 4, 2016
Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT StudyElvin Kedhi, Mark W Kennedy, Akiko Maehara, et al.
The American Journal of Cardiology|June 14, 2003
Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart diseaseMehdi H Shishehbor, Byron J Hoogwerf, Paul Schoenhagen, et al.
JACC. Cardiovascular Imaging|October 21, 2015
Predictors of Plaque Rupture Within Nonculprit Fibroatheromas in Patients With Acute Coronary Syndromes: The PROSPECT StudyBo Zheng, Gary S Mintz, John A McPherson, et al.
Circulation. Cardiovascular Interventions|July 8, 2010
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registryJoshua M Stolker, Kevin F Kennedy, Jason B Lindsey, et al.
Pageof 15